₹ 270.15
Key Takeaways
Risk factor
Very poor trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Greatly undervalued vs peers
Data is available to registered users only
Data is available to registered users only
About
Samrat Pharmachem Ltd. is a company focused on the production and sale of various chemical compounds. Its product offerings feature substances like 3-5–Di iodosalicylic acid, aluminium iodide, clioquinol, ethylenediamine dihydroiodide, copper iodine, and lithium iodide. Lalit Damodar Mehta founded the enterprise on June 16, 1992, and it maintains its primary offices in Mumbai, India.
Company Valuation
Based on key historical and expected multiples, the stock is greatly undervalued relative to its peers.
Data is available to registered users only